A new immunochemical strategy for triple-negative breast cancer therapy

A new immunochemical strategy for triple-negative breast cancer therapy

Abstract Triple-negative breast cancer (TNBC) is a highly diverse group of malignant neoplasms which tend to have poor outcomes, and the development of new targets and strategies to treat these cancers is sorely needed. Antibody–drug conjugate (ADC) therapy has been shown to be a promising targeted...

Full description

Saved in:
Bibliographic Details
Main Authors: Chih-Wei Lin, Tianqing Zheng, Geramie Grande, Alex R. Nanna, Christoph Rader, Richard A. Lerner
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/65dfaed7185b4b46a02f81c93c98f21c
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items